Dimercaptosuccinic acid with membrane-targeting activity against Pseudomonas aeruginosa

Horng-Ren Lo1, Cian-Hui Yan1, Ya Yan2

  • 1Department of Medical Laboratory Science and Biotechnology, Fooyin University, Kaohsiung, Taiwan.

PubMed
Abstract

Insights

Dimercaptosuccinic acid (DMSA) inhibits multidrug-resistant Pseudomonas aeruginosa growth and biofilm formation. DMSA disrupts bacterial outer membrane integrity and impairs energy production, offering a potential strategy against gram-negative bacterial infections.

Area of Science:

  • Microbiology
  • Drug Discovery
  • Antimicrobial Resistance

Background:

  • Multidrug-resistant gram-negative bacteria (GNB) pose a significant global health threat.
  • Outer membrane integrity in GNB relies on divalent cations, presenting a potential target for antimicrobial agents.
  • Dimercaptosuccinic acid (DMSA), a metal chelator, has shown potential in disrupting bacterial structures.

Purpose of the Study:

  • To investigate the effects of DMSA on Pseudomonas aeruginosa.
  • To elucidate the mechanisms of action of DMSA against P. aeruginosa.

Main Methods:

  • Growth kinetics analysis to determine bacterial inhibition.
  • Crystal violet staining for biofilm formation assessment.
  • Propidium iodide (PI) and DiBAC4(3) staining to evaluate outer membrane permeability and cell membrane potential.
  • Assays for intracellular ATP levels, bacterial motility, and NPN efflux to assess bioenergetics.

Main Results:

  • DMSA demonstrated concentration-dependent inhibition of P. aeruginosa growth and repressed biofilm formation.
  • DMSA treatment led to increased PI uptake and enhanced DiBAC4(3) fluorescence, indicating compromised outer membrane and cell membrane potential.
  • Intracellular ATP levels, bacterial motility, and efflux activity were significantly reduced in DMSA-treated P. aeruginosa.

Conclusions:

  • DMSA exhibits antibacterial activity through mechanisms involving disruption of outer membrane permeability and membrane depolarization.
  • Impaired bioenergetics-related activity, including reduced ATP levels and motility, contributes to DMSA's antibacterial effects.
  • DMSA presents a promising therapeutic candidate for combating multidrug-resistant gram-negative bacterial infections.